NCT07436663 Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC Status NOT_YET_RECRUITING Phase PHASE4
NCT07436312 Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer Status RECRUITING Phase NA
NCT07432178 CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer(Cinnamon) Status NOT_YET_RECRUITING Phase PHASE3
NCT07429487 Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer Status NOT_YET_RECRUITING Phase NA
NCT07428720 Axillary Lymph Node Changes After Neoadjuvant Therapy In Breast Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT07428018 Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib Status NOT_YET_RECRUITING Phase PHASE2
NCT07427407 Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers Status NOT_YET_RECRUITING Phase N/A
NCT07426952 Weight Management After Cancer for Survivors in Rural Communities Status SUSPENDED Phase NA
NCT07426913 Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab Status RECRUITING Phase NA
NCT07426809 Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study). Status RECRUITING Phase NA
NCT07426653 Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models. Status COMPLETED Phase N/A
NCT07426510 IRIS: Risk-Based Imaging After Breast-Conserving Surgery Status NOT_YET_RECRUITING Phase NA
NCT07425548 Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer. Status NOT_YET_RECRUITING Phase NA
NCT07425002 Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM) Status RECRUITING Phase NA
NCT07424547 Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT07423611 ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07421141 De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2